Burden, Mortality and Supply Costs in Intensive Care Unit Patients. Health Services Research.

What this Trial Is About

This research aims to observe the relationship between different therapy strategies and treatment outcomes for patients in intensive care units (ICUs) under real-world conditions. It focuses on three initial risk groups—high, intermediate, and low—based on factors such as frailty, disease severity, and the number of organ systems requiring support. The study evaluates three key endpoints: burden of care, mortality, and supply costs. The study includes ICU patients who either stay for at least 72 hours or die within 72 hours of admission. Participants are categorized into risk groups according to the Clinical Frailty Scale, the Simplified Acute Physiology Score II, and the number of organ systems needing support or replacement. The study observes therapy strategies such as maximal therapy, withholding treatment, or withdrawing treatment, assessing their association with treatment success across these groups. Participants will be monitored over an 18-month period to measure burden of care, mortality rates, and supply costs. Data collection will occur under typical clinical conditions without altering standard care. The study systematically tracks patient outcomes related to therapy strategies, aiming to provide insights into intensive care practices and associated resource use.

Burden, Mortality and Supply Costs in Intensive Care Unit Patients